Rad Chat is the multi-award winning, first therapeutic radiographer led oncology podcast, designed for cancer patients, healthcare professionals, academics, and researchers. Naman Julka-Anderson and Jo McNamara are both therapeutic radiographers who have unique backgrounds, bringing specialist knowledge and skills to the conversation. Their guests include people living with and beyond cancer, healthcare professionals, researchers, and leaders within healthcare.
AI-assisted oncology still requires whole-patient data and multidisciplinary validation, while unequal trial representation, inconsistent outcome reporting, affordability and implementation barriers can determine whether promising innovation actually improves access and patient care.
Radiotherapy equipment contracts need to include planning capability, licences, accessories and replacement arrangements, while satellite services illustrate how local access, machine resilience, transport, facility design and advance capacity planning affect what treatment can safely be delivered.
Low-dose radiotherapy is considered as an anti-inflammatory treatment for selected persistent musculoskeletal conditions, while intermediate doses target benign hyperproliferative disease, with patient selection, conservative treatment, anatomy, age, dose and irradiated tissues shaping decisions and consent.
Allied health value is shown through patient experience, clinical outcomes and cost-effectiveness rather than contact numbers alone. Starting with one condition and one measurable outcome helps clinical and finance teams trace delayed benefits across the wider pathway.
Finishing cancer treatment may leave persistent fatigue, cognitive change, fear of recurrence, fertility concerns and difficulty returning to work. Anticipatory conversations, tailored signposting, peer support and flexible workplace planning can support a non-linear recovery.
.svg)